ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1303 • ACR Convergence 2021

    Associations Between Early Changes in Circulating B Cell Subsets and Severe Flare in Systemic Lupus Erythematosus – Results from Three Phase III Trials of Belimumab

    Ioannis Parodis1, Alvaro Gomez2, Julius Lindblom2, Alexander Borg2, Sharzad Emamikia2 and Mariele gatto3, 1Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden and Department of Rheumatology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden, 2Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden, 3Department of Rheumatology, University of Padua, Padua, Italy

    Background/Purpose: Belimumab is the only approved targeted treatment for systemic lupus erythematosus (SLE). Identification of early predictors of response or non-response to therapy is imperative…
  • Abstract Number: 1304 • ACR Convergence 2021

    Increased Risk of Vertebral Fracture Among Patients with Psoriatic Arthritis: A Systematic Review and Meta-analysis

    Patompong Ungprasert1, Nipith Charoenngam2, Ben Ponvilawan3, Jerapas Thongpiya4 and Pitchaporn Yingchoncharoen3, 1Cleveland Clinic, Cleveland Heights, OH, 2Mount Auburn Hospital, Boston, MA, 3Mahidol University, Bangkok, Thailand, 4Mahdiol University, Bangkok, Thailand

    Background/Purpose: Increased risk of vertebral fracture (VF) has been documented in several autoimmune diseases as a result of excessive inflammatory burden and use of corticosteroids.…
  • Abstract Number: 1305 • ACR Convergence 2021

    Undiagnosed Depression in Axial Spondyloarthropathy and the Negative Impact on Patient Outcomes: Results of a Screening Study

    Sinead Maguire1, Phil Gallagher2 and Finbar (Barry) O'Shea1, 1St James's Hospital, Dublin, Ireland, 2St Vincent's Hospital, Dublin, Ireland

    Background/Purpose: Previous research in axial spondyloarthropathy(axSpA) has shown this population to have a high prevalence of depression. This co-morbidity has been previously shown to impact…
  • Abstract Number: 1306 • ACR Convergence 2021

    Clinical and Imaging Characteristics of Spondyloarthritis Among Crohn’s Disease Patients

    Laarni Quimson1, Nisa Oren2, Catherine Burns3 and Reem Jan2, 1University of Chicago, Oak Park, IL, 2University of Chicago, Chicago, IL, 3Indiana University, Indianapolis, IN

    Background/Purpose: Inflammatory bowel disease (IBD) affects up to 1.3% of the population and is associated with musculoskeletal manifestations including spondyloarthritis (SpA). Axial SpA (axSpA) is…
  • Abstract Number: 1307 • ACR Convergence 2021

    Uveitis in Spondyloarthritis Patients. Is There Any Specific Clinical Picture?

    MARIA LLOP VILALTELLA1, Mireia moreno1, Marta Arévalo1, Jordi Gratacós1, Maxime Dougados2 and Clementina López Medina3, 1Parc Taulí Hospital Universitari. Institut d’Investigació i Innovació Parc Taulí I3PT, Sabadell, Spain, 2Université de Paris . Department of Rheumatology - Hôpital Cochin. Assistance Publique - Hôpitaux de Paris . INSERM (U1153): Clinical epidemiology and biostatistics, PRES Sorbonne Paris-Cité. Paris, France., Paris, France, 3Department of Rheumatology, Reina Sofia Hospital, IMIBIC, University of Cordoba, Cordoba, Spain/ Department of Rheumatology, University of Paris, Cochin Hospital, Paris, France

    Background/Purpose: Uveitis is the most frequent extra-musculoskeletal manifestation in Spondyloarhtritis (SpA). Moreover, up to 50% of patients with an acute episode of uveitis develop recurrent…
  • Abstract Number: 1308 • ACR Convergence 2021

    Higher Prevalence of Echocardiographic Abnormalities in Psoriatic Arthritis and Rheumatoid Arthritis Patients Compared to Controls

    Alejandra Rodriguez-Romero, Jose Azpiri-Lopez, Dionicio Galarza-Delgado, Iris Colunga-Pedraza, Natalia Guajardo-Jauregui, Julieta Loya-Acosta, Alejandro Meza-Garza, Jesus Cardenas-de La Garza, Salvador Lugo-Perez, Catalina Andrade-Vazquez and Alan De Leon-Yañez, Hospital Universitario "Dr Jose E. Gonzalez", Monterrey, Mexico

    Background/Purpose: Psoriatic arthritis (PsA) is a chronic inflammatory arthropathy associated with cardiovascular abnormalities. The echocardiography is a non-invasive tool useful in the detection of cardiac…
  • Abstract Number: 1309 • ACR Convergence 2021

    Impact of the Number of Comorbidities on the Outcome Measures and on the Retention Rate of the First Anti-TNF in Patients with Ankylosing Spondylitis: Two-year Follow-up REGISPONSER-AS

    Mara ngeles Puche Larrubia1, M.Lourdes Ladehesa-Pineda1, Pilar Font2, Alejandro Escudero Contreras3, Eduardo Collantes-Estevez2 and Clementina López Medina4, 1Hospital Universitario Reina Sofía, Córdoba, Spain, 2IMIBIC/Reina Sofia Hospital/University of Córdoba, Córdoba, Spain, 3Hospital Universitario Reina Sofía/IMIBIC/Universidad de Córdoba., Cordoba, Spain, 4Department of Rheumatology, Reina Sofia Hospital, IMIBIC, University of Cordoba, Cordoba, Spain/ Department of Rheumatology, University of Paris, Cochin Hospital, Paris, France

    Background/Purpose: a) To evaluate the impact of the number of comorbidities on the outcome measures after two years of follow-up in patients with ankylosing spondylitis…
  • Abstract Number: 1310 • ACR Convergence 2021

    Clinical Characteristics of Patients with SpA and Concomitant IBD: Results from the ASAS PerSpA Study

    Keisuke Ono1, Mitsumasa Kishimoto2, Gautam Deshpande3, Sho Fukui4, Satoshi Kawaai5, Haruki Sawada6, Minoru Matsuura7, Valeria Rios Rodriguez8, Fabian Proft8, Kurisu Tada6, Naoto Tamura6, Yoshinori Taniguchi9, Ayako Hirata10, Hideto Kameda10, Shigeyoshi Tsuji11, Yuko Kaneko12, Hiroaki Dobashi13, Tadashi Okano14, Yoichiro Haji15, Akimichi Morita16, Akihiko Asahina17, Masato Okada18, Yoshinori Komagata1, Clementina López Medina19, Anna Molto20, Désirée van der Heijde21, Maxime Dougados22, Tadakazu Hisamatsu7, Tetsuya Tomita23 and Shinya Kaname1, 1Department of Nephrology and Rheumatology, Kyorin University School of Medicine, Tokyo, Japan, 2Department of Nephrology and Rheumatology, Kyorin University School of Medicine, Yokohama, Japan, 3Department of General Internal Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan, 4Immuno-Rheumatology Center, St. Luke’s International Hospital, and Center for clinical epidemiology, St. Luke’s International University, Tokyo, Japan, 5Immuno-Rheumatology Center, St. Luke’s International Hospital, Tokyo, Japan, Chuo-ku, Tokyo, Japan, 6Department of Internal Medicine and Rheumatology, Juntendo University Faculty of Medicine, Tokyo, Japan, 7Department of Gastroenterology and Hepatology, Kyorin University School of Medicine, Tokyo, Japan, 8Charité University Medicine Berlin, Berlin, Germany, 9Department of Endocrinology, Metabolism and Nephrology, Kochi Medical School, Kochi, Japan, 10Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Toho University, Tokyo, Japan, 11Department of Orthopedics and Rheumatology, National Hospital Organization Osaka Minami Medical Center, Osaka, Japan, 12Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan, 13Department of Internal Medicine, Division of Hematology, Rheumatology and Respiratory Medicine, Faculty of Medicine, Kagawa University, Kita-gun, Japan, 14Department of Orthopedic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan, 15Department of Rheumatology, Daido Hospital, Nagoya, Japan, 16Department of Geriatric and Environmental Dermatology, Nagoya City University, Nagoya, Japan, 17Department of Dermatology, The Jikei University School of Medicine, Tokyo, Japan, 18Immuno-Rheumatology Center, St. Luke’s International Hospital, Tokyo, Japan, 19Department of Rheumatology, Reina Sofia Hospital, IMIBIC, University of Cordoba, Cordoba, Spain/ Department of Rheumatology, University of Paris, Cochin Hospital, Paris, France, 20Rheumatology department, Cochin hospital, APHP, Paris, France, 21Department of Rheumatology, Leiden University Medical Center, Meerssen, Netherlands, 22Université de Paris . Department of Rheumatology - Hôpital Cochin. Assistance Publique - Hôpitaux de Paris . INSERM (U1153): Clinical epidemiology and biostatistics, PRES Sorbonne Paris-Cité. Paris, France., Paris, France, 23Department of Orthopaedic Biomaterial Science, Osaka University Graduate School of Medicine, Suita Osaka, Japan

    Background/Purpose: A recent study reports that gut inflammation is linked to degree of bone marrow edema in sacroiliac joints in patients with axial spondyloarthritis (SpA).…
  • Abstract Number: 1311 • ACR Convergence 2021

    De Novo Psoriasis Can Be Reported at Any Timepoint in Early Axial Spondyloarthritis: An Analysis of 6 Years of Follow-up of the DESIR Cohort

    Florian LUCASSON1, Pascal Richette2, krystel aouad1, Adeline RUYSSEN-WITRAND3, Daniel Wendling4, Bruno Fautrel5 and Laure Gossec6, 1Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France, 2Lariboisiere Hospital, Paris, France, 3Toulouse University Hospital, Centre d'Investigation Clinique de Toulouse CIC1436, Inserm, Paul Sabatier University,, Toulouse, France, 4Service de rhumatologie, CHU de Besançon, Besançon, France, 5Pitié Salpêtrière Hospital, APHP, Sorbonne Université, Paris, France, 6Sorbonne Université; APHP, Rheumatology Department, Pitié-Salpêtrière Hospital, Paris, France

    Background/Purpose: Psoriasis is a frequent extra-articular manifestation in axial spondyloarthritis (axSpA) with a prevalence in established axSpA around 9% and consequences on the disease course.…
  • Abstract Number: 1312 • ACR Convergence 2021

    What Is the Optimal Screening Strategy for Early Recognition of Spondyloarthritis in Patients with Acute Anterior Uveitis?

    Judith Rademacher1, Hanna Müllner2, Dominika Pohlmann3, Valeria Rios Rodriguez1, Fabian Proft1, Mikhail Protopopov1, Susanne Lüders4, Burkhard Muche5, Laura Spiller1, Anne-Katrin Weber2, Sabrina Sron2, Hildrun Haibel6, Uwe Pleyer3 and Denis Poddubnyy7, 1Charité University Medicine Berlin, Berlin, Germany, 2Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin; Department of Gastroenterology, Infectiology and Rheumatology (including Nutrition Medicine), Berlin, Germany, 3Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin; Department of Ophthalmology, Berlin, Germany, 4Department of Gastroenterology, Infectiology and Rheumatology (including Nutrition Medicine), Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany, Berlin, Germany, 5Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Gastroenterology, Infectiology and Rheumatology (including Nutrition Medicine), Berlin, Germany, 6Department of Gastroenterology, Infectiology and Rheumatology (including Nutrition Medicine), Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany, 7Department of Rheumatology, Charité – Universitätsmedizin, Berlin, Germany

    Background/Purpose: The diagnostic delay remains long in patients with spondyloarthritis (SpA), thus effective screening/referral strategies for early recognition are needed. Up to 40% of patients…
  • Abstract Number: 1313 • ACR Convergence 2021

    The Impact of Comorbidities on Patients with Axial Spondyloarthritis: A Cluster Analysis

    Seulkee Lee, Seonyoung Kang, Yeonghee Eun, Hyungjin Kim, Hoon-Suk Cha, Eun-Mi Koh and Jaejoon Lee, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea

    Background/Purpose: Previous study using cluster analysis technique analyzed the association between comorbidities and various outcome measures in patients with axial spondyloarthritis (axSpA). Due to the…
  • Abstract Number: 1314 • ACR Convergence 2021

    Predictive Factors for the Development Acute Anterior Uveitis Attacks in Patients with Axial Spondyloarthritis; The Results of a Longitudinal Analysis

    Haluk Cinaklı1, Elif Ediboglu1, Eda Otman Akat2, Dilek Solmaz3, Gulay Alp1, Esra Erpek1, Sercan Gücenmez4, Mustafa Ozmen4 and Servet Akar3, 1Izmir Katip Celebi University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, İzmir, Turkey, 2katip çelebi, izmir, Turkey, 3Izmir Katip Celebi University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Izmir, Turkey, 4katip çelebi university, izmir, Turkey

    Background/Purpose: Axial spondyloarthritis (axSpA) is a chronic inflammatory rheumatic disease mainly affecting sacroiliac joints and spine. Peripheral arthritis, dactylitis and enthesitis may also occur. Acute…
  • Abstract Number: 1315 • ACR Convergence 2021

    The Best Cardiovascular Risk Algorithm to Predict the Presence of Carotid Plaque in Psoriatic Arthritis Patients

    Natalia Guajardo-Jauregui, Iris Colunga-Pedraza, Jose Azpiri-Lopez, Dionicio Galarza-Delgado, Alejandra Rodriguez-Romero, Diana Flores-Alvarado, Julieta Loya-Acosta, Alejandro Meza-Garza, Jesus Cardenas-de La Garza, Salvador Lugo-Perez and Jessica Castillo-Treviño, Hospital Universitario "Dr Jose E. Gonzalez", Monterrey, Mexico

    Background/Purpose: Systemic inflammation in psoriatic arthritis (PsA) patients accelerates the process of atherosclerosis; this increases the risk of presenting a major cardiovascular (CV) event than…
  • Abstract Number: 1316 • ACR Convergence 2021

    Vitamin D Deficiency and Disease Activity in Patients with Spondyloarthritis

    Maria Rato1, Filipe Pinheiro1, Salomé Garcia1, Bruno Fernandes2, Ana Martins1, Daniela Oliveira1, Frederico Martins3, Diogo Fonseca4, Alexandra Bernardo1, Miguel Bernardes1 and Lúcia Costa1, 1Rheumatology Department, Centro Hospitalar Universitário de São João EPE, Porto, Portugal, 2Rheumatology Department, Centro Hospitalar Universitário de São João EPE, Braga, Portugal, 3Rheumatology Department, Centro Hospitalar Universitário do Algarve EPE, Algarve, Portugal, 4Rheumatology Department, Centro Hospitalar de Vila Nova de Gaia/Espinho, EPE, Gaia, Portugal

    Background/Purpose: There are increasing data about vitamin D immunomodulatory potential in different rheumatologic disorders. Deficiency of vitamin D is frequent in patients with spondyloarthritis (SpA)…
  • Abstract Number: 1317 • ACR Convergence 2021

    Impairment of Memory in Axial Spondyloarthritis?

    Stefan Kleinert1, Florian Schuch2, Praxedis Rapp2, Monika Ronneberger2, Joerg Wendler2, Patrizia Sternad3, Florian Popp3, Peter Bartz-Bazzanella4, Cay Von der Decken5, Kirsten Karberg6, Georg Gauler7, Patrick Wurth8, Susanna Späthling-Mestekemper9, Christoph Kuhn10, Mathias Englbrecht11, Wolfgang Vorbrüggen12, Georg Adler13 and Martin Welcker14, 1Praxisgemeinschaft Rheumatologie - Nephrologie (PGRN), Erlangen, Germany, 2Praxisgemeinschaft Rheumatologie-Nephrologie, Erlangen, Germany, 3Medizinisches Versorgungszentrum für Rheumatologie Dr. M. Welcker GmbH, Planegg, Germany, 4Rhein-Maas Klinikum, Wuerselen, Germany, 5Klinik für Internistische Rheumatologie, Rhein-Maas-Klinikum, Würselen, Germany, 6Praxis für Rheumatologie und Innere Medizin, Berlin, Germany, Berlin, Germany, 7rheumapraxis, Osnabrck, Germany, 8Rheumatologische Schwerpunktpraxis, Osnabrück, Germany, 9Rheumapraxis München, München, Germany, 10Praxis für Rheumatologie, Karlsruhe, Germany, Karlsruhe, Germany, 11Freelance Healthcare Data Scientist, Eckental, Germany., Eckental, Germany, 12Verein zur Förderung der Rheumatologie e.V., Würselen, Germany, 13Institut für Studien zur Psychischen Gesundheit (ISPG), Mannheim, Germany, 14MVZ für Rheumatologie, Planegg, Germany

    Background/Purpose: There is certain evidence that neuropsychiatric changes occur in systemic lupus(1) and rheumatoid arthritis (2). However, there is little knowledge about possible cognitive changes…
  • « Previous Page
  • 1
  • …
  • 790
  • 791
  • 792
  • 793
  • 794
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology